(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 3.79% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Revvity's revenue in 2025 is $2,813,367,000.On average, 22 Wall Street analysts forecast RVTY's revenue for 2025 to be $329,016,052,142, with the lowest RVTY revenue forecast at $315,524,353,243, and the highest RVTY revenue forecast at $339,673,360,516. On average, 22 Wall Street analysts forecast RVTY's revenue for 2026 to be $339,106,482,411, with the lowest RVTY revenue forecast at $323,800,773,576, and the highest RVTY revenue forecast at $357,813,459,876.
In 2027, RVTY is forecast to generate $358,493,713,602 in revenue, with the lowest revenue forecast at $338,539,604,306 and the highest revenue forecast at $384,796,857,674.